At a glance
Read the record in context
Dihexa's unusually long stored interval has an unusually important qualifier: intravenous rat data. Its oral and subcutaneous logging options do not validate that duration in humans. The empty package field is deliberate because the source library supplies no typical vial to calculate from.[1]
What the research says
The cited preclinical paper explored chemical modifications of angiotensin IV-related peptides to improve stability and barrier penetration. Researchers evaluated candidate compounds in rat models of impaired learning and in experiments on synapse formation. Dihexa emerged as an orally active analog within that development program.[2]
Measured outcomes included performance in a water-maze learning task and hippocampal synaptogenesis. Experiments used both pharmacologically induced impairment and aged rats. These methods address behavior and cellular connectivity in animal systems; neither is a clinical measure of cognitive benefit in a human population.[2]
The publication also discusses metabolic stabilization as a design objective. Its animal results do not establish a human response or a general dosing schedule. PinPoint's long-duration tracking input remains tied to preclinical context, and the absence of a sourced vial package prevents an invented injectable preparation example.[2][1]
Cited amounts
The library does not supply a typical vial amount for this entry. This guide therefore reports no vial total or human dosing range and does not infer one from the half-life.[1]
Open the calculator for amount conversionsHalf-life and timing
The 304-hour input equals approximately 12.67 days when divided by 24. Two halvings therefore occupy 608 hours, and five occupy 1,520 hours, approximately 63.33 days. At the final point, the model retains 3.125%. The decimals are calculated from a rounded stored value; the source note describes about 12.68 days. Neither form supports a two-month personal clearance claim. The long bar still inherits the rat intravenous context and lacks measured human oral or subcutaneous absorption.[1][4]
Continue to the calculatorReconstitution
A concentration requires both an amount and a liquid volume. Neither a typical Dihexa vial total nor a final preparation volume is provided by this entry. Substituting a familiar peptide package would add an unsupported fact, even if the subsequent division were mathematically correct. The general calculator can handle independently known inputs, but this guide cannot prefill them from a 304-hour time value. The absence of a worked liquid number is therefore a property of the source coverage, not a missing arithmetic formula.[1]
Tracking it in PinPoint
From a reference to a record
Built for peptide, TRT, and GLP-1 schedules. Set up your vial in seconds, log every dose, and see your modeled levels between doses. Enter vial size in mg, mcg, or IU and water volume for instant concentration and syringe units. Track vials and prefilled pens side by side.[3]
The Home curve models your levels between doses from published half-life data. Drag to scrub modeled values at any timestamp, or preview 30 days of a dose pattern. Ask PinPoint provides educational reference with sources; it never recommends a dose or a schedule change. These features record and visualize entered information, with the limits of each compound's source data still applying.
Get PinPoint on the App StoreFrequently asked questions
- Does the Dihexa half-life describe a human oral preparation?
- No. The library identifies an intravenous rat reference and uses 304 hours for local modeling. Oral and subcutaneous logging options do not establish route-specific human evidence. The five-half-life calculation inherits all of those limitations.[1][2]
- Why is there no Dihexa vial total in the facts card?
- The application library does not provide one. The guide preserves that absence instead of assigning a catalog package from another compound. Without a sourced total, a specific reconstitution quotient would rest on an invented input.[1][4]
- Does Dihexa's long interval establish two months of human persistence?
- The model's five-interval span is calculated from an intravenous rat reference. It is not measured human oral or subcutaneous persistence. The guide reports the large arithmetic value with that limitation rather than converting it into a personal timing claim.[1][4]
- Can a peptide tracker app record Dihexa?
- PinPoint's compound library includes Dihexa. The app description covers logging compound, dose, site, and pain level, as well as viewing modeled levels between recorded doses. The curve uses published reference inputs and does not account for individual variation. The tracker records the schedule entered by its user; it does not choose a dose or recommend a schedule change.[1][3]
Sources
Facts and reference links were retrieved from the PinPoint application library on 5 October 2026. Links below preserve the library's citations; a catalog source supports a package amount only. Source references carried from the library have not all been independently reverified. Arithmetic examples are identified separately from clinical evidence.
- PinPoint compound library, DihexaSnapshot of the application library; its references and uncertainty are retained below.Retrieved 2026-10-05 · library
- PubMed pharmacology reference 23055539Identity and research summary checked against this document on 5 October 2026. PubMed abstract, retrieved through NCBI EFetch.Retrieved 2026-10-05 · library-reference
- PinPoint App Store descriptionFeature wording from the approved application description, not pricing.Retrieved 2026-10-05 · app-description
- Unit conversion and exponential-decay arithmeticC = amount / volume; remaining fraction = 2^(-elapsed / half-life). These are illustrations, not measurements.Retrieved 2026-10-05 · arithmetic